国际药品价格谈判框架的比较分析:对关键利益相关者的采访研究
Iselin Dahlen Syversen1,2, Kevin Schulman2, Aaron S Kesselheim1
1Brigham and Women's Hospital and Harvard Medical School.
The Milbank quarterly
|September 18, 2024
概括
国际药品价格谈判框架为美国提供了宝贵的教训. 纳入早期价格谈判和临床评估等要素可以增强医疗保险.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 医疗保健系统比较分析分析
背景情况:
- "通货膨胀减少法" (IRA) 允许医疗保险在2022年首次谈判处方药价格.
- 许多工业化国家已经建立了谈判药品价格的框架.
研究的目的:
- 为了比较和对比跨国际卫生系统的药品价格谈判流程.
- 确定谈判框架的关键特征,这些特征在当前的美国医疗保险体系中不存在.
主要方法:
- 对八个国际系统 (加拿大,法国,德国,英国,比利时,荷兰,挪威和美国退伍军人事务) 的分析.
- 收集立法,政府出版物,并与谈判代表进行半结构化采访.
- 使用开发的内部评估工具分析数据.
主要成果:
- 所有分析的系统都在批准后谈判品牌药物价格,并使用临床评估.
- 临床评估机构,健康益处评估,支付意愿门和优先疾病领域方法的分离存在关键差异.
结论:
- 国际药品价格谈判框架共享在当前的医疗保险框架中基本上缺少的共同做法.
- 美国决策者可以通过考虑这些既有国际方法的要素来改善谈判结果.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
145
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
145
Drug Concentrations: Measurements
342
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
342
Agonism and Antagonism: Quantification
331
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
331
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Analysis of Population Pharmacokinetic Data
239
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
239


